Gujarat Alkalies Approves 550 Million Rupee Dahej HCL Expansion

VADODARA — Gujarat Alkalies and Chemicals Limited (NSE: GUJALKALI, BSE: 530001) has formally approved a capital expenditure proposal to install a new Hydrochloric Acid (HCL) Synthesis Unit at its manufacturing complex in Dahej, Gujarat. The expansion project carries an estimated investment outlay of ₹550 million (₹55 crore).

The board's strategic capex authorization was announced alongside GACL's consolidated financial results for the quarter ending June. During the quarterly period, the state-promoted chemical manufacturer logged consolidated revenue from operations of ₹12.45 billion (₹1,245 crore). The company achieved a consolidated net profit of ₹549.8 million (₹54.98 crore), supported by volume growth in its core chlor-alkali segment and specialized derivative product lines.

The addition of the HCL synthesis unit aligns with GACL's strategy of expanding downstream derivative capacity to effectively utilize chlorine generated during the caustic soda production process.

Project Specifications and Capital Allocation

The newly approved HCL Synthesis Unit at Dahej is designed to absorb excess chlorine gas and convert it into industrial-grade Hydrochloric Acid, a key chemical feed for pharmaceuticals, steel pickling, water treatment, and agrochemical industries.

Key elements of the capital project include:

• Project Outlay: Approximately ₹550 million (₹55 crore).

• Plant Location: Dahej Chemical Complex, District Bharuch, Gujarat.

• Strategic Objective: Effective utilization of byproduct chlorine, mitigating storage constraints, and augmenting high-margin derivative product sales.

• Funding Mechanism: Funded primarily through internal accruals and existing capital lines.

By adding downstream synthesis capacity, GACL mitigates risks associated with liquid chlorine transport regulations and seasonal volatility in raw chlorine merchant prices.

June Quarter Financial Analysis and Industry Trends

GACL's June quarter financial metrics underscore operational recovery following periods of margin compression caused by fluctuating global caustic soda realizations and elevated energy inputs.

• Consolidated Revenue from Operations: ₹12.45 billion (₹1,245 crore), reflecting steady off-take from domestic industrial consumers.

• Consolidated Net Profit: ₹549.8 million (₹54.98 crore), driven by plant capacity utilization and cost optimization across manufacturing units.

• Market Position: GACL remains one of India's largest chlor-alkali producers, with integrated facilities at Vadodara and Dahej serving textiles, paper, alumina, and water treatment sectors.

The company's focus on expanding downstream derivatives—such as Chloromethanes, Hydrogen Peroxide, Phosphoric Acid, and Hydrochloric Acid—helps cushion its overall balance sheet against cyclical swings in the primary caustic soda market.

Official Sources Statement

In official regulatory filings submitted to Indian stock exchanges, Gujarat Alkalies and Chemicals Limited confirmed the board decisions:

"According to official regulatory filings, the Board of Directors of Gujarat Alkalies and Chemicals Limited has approved the setting up of one more HCL Synthesis Unit at its Dahej Complex at an estimated cost of ₹550 million, while also approving consolidated quarterly financial results featuring revenue from operations of ₹12.45 billion and a net profit of ₹549.8 million."

The company confirmed that the financial statements were audited by statutory auditors and reviewed by the Audit Committee prior to board approval, in accordance with Securities and Exchange Board of India (SEBI) requirements.

Why It Matters

The dual announcement of the Dahej plant expansion and solid quarterly profitability carries several practical implications for investors, chemical consumers, and industrial markets:

1. Environmental & Operational Safety: Converting chlorine to HCL on-site reduces the need for long-distance transport of hazardous chlorine gas.

2. Supply Chain Reliability: Industrial consumers in the Dahej manufacturing hub gain access to an expanded domestic supply of Hydrochloric Acid.

3. Earnings Diversification: Downstream integration enhances GACL's margin stability, supporting sustainable return metrics for shareholders.

Key Facts at a Glance

• Company: Gujarat Alkalies and Chemicals Limited (NSE: GUJALKALI | BSE: 530001)

• New Capex Approval: Additional HCL Synthesis Unit at Dahej

• Project Investment: Estimated at ₹550 million (₹55 crore)

• June Quarter Revenue: ₹12.45 billion (₹1,245 crore)

• June Quarter Net Profit: ₹549.8 million (₹54.98 crore)

Frequently Asked Questions (FAQs)

What does Gujarat Alkalies and Chemicals Limited produce?

GACL is a major Indian chemical producer specializing in caustic soda, chlorine, hydrochloric acid, hydrogen peroxide, chloromethanes, caustic potash, and aluminum chloride used across industrial sectors.

What is the purpose of the new HCL unit at Dahej?

The new HCL Synthesis Unit will convert byproduct chlorine into Hydrochloric Acid, improving chlorine integration, enhancing plant safety, and increasing sales of value-added chemical derivatives.

Where are GACL's primary manufacturing units located?

GACL operates two primary integrated manufacturing complexes in Gujarat: one at Vadodara and the second at the PCPIR chemical zone in Dahej.

Where can investors track GACL's corporate disclosures?

Investors can track official corporate filings on the National Stock Exchange of India (NSE), BSE Limited, and GACL's official portal GACL Investor Relations.

Source: Regulatory filings submitted to National Stock Exchange of India, BSE Limited, official announcements from Gujarat Alkalies and Chemicals Limited, and notifications from the Government of Gujarat.